Research into developing new antimicrobial resistance treatment in Nigeria and other low/middle-income countries has fuelled a $50 million investment. The
read more Disease resistance treatment fuels $50m investmentBusinessday NGRead More
Reward Investments & Services Ltd
(Member of the Nigerian Stock Exchange)
(Participating Institution of the NASD OTC Secutities & Exchange)
Research into developing new antimicrobial resistance treatment in Nigeria and other low/middle-income countries has fuelled a $50 million investment. The
read more Disease resistance treatment fuels $50m investmentBusinessday NGRead More
Powered by MTL
© 2020-Reward Investments & Services Ltd. All rights reserved.